BomedemstatBomedmestat (USAN; IUPAC name N-[(2S)-5-(1R,2S)-2-(4-fluorophenyl)cyclopropyl]amino]-1-(4-methylpiperazin-1-yl)-1-oxopentan-2-yl]-4-(triazol-1-yl)benzamide) is an investigational drug under development by Imago BioSciences for the treatment of myeloproliferative neoplasms including [[essential thrombocythemia,… Read from the Drugbox of the Wikipedia article Bomedemstat, revision 1324499767.

Property

Value

Formula

C28H34FN7O2, 519.62 g/mol

The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.